To find the potential targets of USP1 in DLBCL, we first analyzed the proteins interacting with USP1 in the GEO database, and the results showed that the expression levels of MAX in DLBCL patient samples were significantly higher than those of healthy controls (Supplementary Fig. S3a). This evidence concerns the gene MAX and diffuse large B-cell lymphoma.